As a male who kissed a partner, received oral sex, and briefly performed oral‑anal contact, what is the risk of HIV transmission to me given that the partner is HIV‑negative but his pre‑exposure prophylaxis (PrEP) status is unknown?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Your HIV Transmission Risk is Essentially Zero

Given that your partner is HIV-negative, you have no risk of HIV transmission from this encounter, regardless of the sexual activities performed. HIV can only be transmitted from someone who actually has the virus.

Why Your Risk is Zero

The fundamental principle here is straightforward: HIV transmission requires a source of HIV. Since your partner does not have HIV, there is no virus to transmit to you 1. His PrEP status is completely irrelevant in this scenario—PrEP (pre-exposure prophylaxis) is a medication HIV-negative people take to prevent acquiring HIV from future exposures. Whether he takes it or not has no bearing on your risk when he's already HIV-negative.

Understanding the Activities and Their Theoretical Risks

For educational context, if your partner had been HIV-positive, here's what the transmission risks would have been:

Kissing

  • Zero transmission risk - HIV is not transmitted through saliva or kissing 2

Receiving Oral Sex

  • Zero transmission risk - There is no documented risk of HIV transmission to the person receiving oral sex

Performing Brief Oral-Anal Contact (Rimming)

  • Extremely low to negligible risk - While the CDC guidelines note that "the per-act risk for HIV transmission from oral sex is substantially lower" than other activities 3, oral-anal contact specifically carries minimal to no documented HIV transmission risk
  • The oral cavity has multiple protective factors including lower concentrations of target cells, salivary antibodies, and antiviral factors that make it an extremely uncommon transmission route 2

For Comparison (If Partner Were HIV-Positive)

The CDC guidelines provide these per-act transmission risks for consensual sex 3:

  • Receptive anal intercourse: 0.5-3%
  • Insertive vaginal intercourse: 0.1-0.2%
  • Oral sex: substantially lower than the above
  • Research suggests receptive oral sex carries approximately 0.04% per-act risk 4

No Action Needed

You do not need:

  • HIV testing (though routine screening is good practice for sexually active individuals)
  • Post-exposure prophylaxis (nPEP)
  • Any medical intervention

Important Caveat

This assessment assumes your partner's HIV-negative status is accurate and based on recent testing. If there's any uncertainty about his actual HIV status, that would change the risk assessment entirely. The CDC recommends HIV testing at 6 weeks, 3 months, and 6 months after potential exposure when source status is uncertain 3.

References

3
Guideline

sexually transmitted diseases treatment guidelines, 2015.

MMWR Recommendations and Reports, 2015

Related Questions

If a patient is exposed to blood on intact skin after a fight and the source's HIV status is unknown, is HIV post‑exposure prophylaxis indicated?
What is the appropriate post‑exposure prophylaxis (PEP) regimen for a 27‑year‑old male who may have been exposed to HIV?
Can human immunodeficiency virus (HIV) be transmitted through oral sex?
Which antiretroviral (HIV) medications can cause clinically significant acid‑base disturbances, and how should these disturbances be monitored and managed?
For a 37‑year‑old female with a 2 cm cutting wound on the ventral aspect of the right wrist caused by a pliers injury, what is the appropriate HIV post‑exposure prophylaxis regimen and which related laboratory tests should be performed as part of the protocol?
In a patient with massive ascites due to an ovarian tumor and a preserved left ventricular ejection fraction, can the ascites cause an elevated N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level?
What is the prevalence of BRAF V600E mutation in poorly differentiated lung acinar adenocarcinoma?
In a patient with a history of prostate cancer, should I order a diagnostic prostate-specific antigen (PSA) test now rather than a routine screening PSA to assess for biochemical recurrence?
What is the recommended protocol to switch a patient from Lybalvi (olanzapine/fluoxetine) to oral aripiprazole (Abilify) and then to the long‑acting injectable aripiprazole?
What is the appropriate iron supplement dosing regimen for an elderly patient, including initial oral dose, adjustments for gastrointestinal intolerance, and criteria for switching to intravenous iron?
What are the benefits of initiating methadone maintenance in a hospitalized patient with chronic injection opioid use compared to the risk of respiratory depression?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.